Letter by Lozano et al regarding article, "Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent)".
Iñigo
I
Lozano
Oliva C
OC
Fernández-Cimadevilla
Vicente
V
Barriales
D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000453:epidemiology / Q000628:therapy*; D054855:Drug-Eluting Stents / Q000706:statistics & numerical data*; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D019106:Postoperative Hemorrhage / Q000209:etiology* / Q000517:prevention & control; D019919:Prosthesis Implantation / Q000009:adverse effects*; D012307:Risk Factors; D016019:Survival Analysis; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D028761:Withholding Treatment
D000077144:Clopidogrel; D013988:Ticlopidine